Curaleaf Holdings (CURLF) Return on Capital Employed (2020 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Return on Capital Employed of 0.46% for Q4 2024, down 63.0% year-over-year from 1.24% in Q1 2024, and down 26.21% quarter-over-quarter from 0.62% in Q3 2024.
Curaleaf Holdings (CURLF) Return on Capital Employed (2020 - 2024) Analysis & Trends
Curaleaf Holdings' Return on Capital Employed history runs 5 years deep, the most recent figure standing at 0.46% for Q4 2024.
- In Q4 2024, Return on Capital Employed fell 63.0% year-over-year to 0.46%; the TTM figure through Dec 2024 stood at 0.46% (down 63.0% YoY), while the FY2025 annual figure was 0.98%, up 4.0% from the prior year.
- Return on Capital Employed for Q4 2024 stood at 0.46%, down from 0.62% in the prior quarter.
- The five-year high for Return on Capital Employed was 40.6% in Q3 2022, with the low at 1.94% in Q3 2023.
- The 5-year median for Return on Capital Employed is 3.67% (2020), against an average of 6.21%.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed jumped 3512 bps in 2022, then plunged 4254 bps in 2023.
- Curaleaf Holdings' Return on Capital Employed stood at 3.08% in 2020, then jumped by 181 bps to 8.68% in 2021, then jumped by 368 bps to 40.6% in 2022, then sank by 97 bps to 1.08% in 2023, then plunged by 58 bps to 0.46% in 2024.
- Business Quant data shows CURLF's Return on Capital Employed at 0.46% in Q4 2024, 0.62% in Q3 2024, and 1.08% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.46% |
| Sep 30, 2024 | 0.62% |
| Dec 31, 2023 | 1.08% |
| Sep 30, 2023 | -1.94% |
| Sep 30, 2022 | 40.60% |
| Jun 30, 2022 | 7.48% |
| Mar 31, 2022 | -0.03% |
| Dec 31, 2021 | 8.68% |
| Sep 30, 2021 | 5.47% |
| Jun 30, 2021 | 4.77% |
| Mar 31, 2021 | 4.25% |
| Dec 31, 2020 | 3.08% |